Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $14.44 and last traded at $14.44, with a volume of 835 shares trading hands. The stock had previously closed at $15.40.
Wall Street Analysts Forecast Growth
Several analysts have weighed in on TLX shares. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a "strong-buy" rating in a research note on Tuesday, November 19th. UBS Group started coverage on Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They issued a "buy" rating and a $21.00 target price on the stock.
Read Our Latest Research Report on TLX
Telix Pharmaceuticals Limited American Depositary Shares Trading Down 2.6 %
About Telix Pharmaceuticals Limited American Depositary Shares
(
Get Free Report)
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
See Also
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
